Hans Gerdes

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

46h-index11.2kcitations215works15.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(76), Esophageal and GI Pathology(59), Esophageal Cancer Research and Treatment(58), Pancreatic and Hepatic Oncology Research(37), Gastrointestinal Tumor Research and Treatment(20)

Publications215 total

376. FEASIBILITY AND ACCURACY OF SENTINEL LYMPH NODE IDENTIFICATION USING INDOCYANINE GREEN IN ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA
Diseases of the Esophagus·2025
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network·2025· 74 cited
Biologically targeted discovery-replication scan identifies G×G interaction in relation to risk of Barrett’s esophagus and esophageal adenocarcinoma
Human Genetics and Genomics Advances·2025Open Access
Tu1310 GASTROSTOMY BEFORE ESOPHAGECTOMY SHOULD NOT AFFECT UTILIZATION OF THE GASTRIC CONDUIT
Gastroenterology·2024
Treatment of esophageal adenocarcinoma in patients with a history of bariatric surgery
Journal of Gastrointestinal Surgery·2024· 2 citedOpen Access
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
JNCI Journal of the National Cancer Institute·2023· 26 citedOpen Access
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
The Lancet Oncology·2023· 39 citedOpen Access
Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors
The Oncologist·2023· 17 citedOpen Access
Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Tables S1-S5 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
Tables S1-S5 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Mark Schattner(18), Vivian E. Strong(13), David H. Ilson(10), Murray F. Brennan(10), Arnold J. Markowitz(9), Jaffer A. Ajani(8), Thomas A. D’Amico(8), Prajnan Das(8), Wayne L. Hofstetter(8), Lawrence Kleinberg(8), Mary F. Mulcahy(8), Christopher G. Willett(8), David J. Bentrem(8), Daniel G. Coit(8), Laura H. Tang(8), Rajesh N. Keswani(7), Charles J. Lightdale(7), Peter J. Allen(7), Nicole R. McMillian(6), Crystal S. Denlinger(6)